Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

774 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database".
Sakamoto T, Miyamoto H, Hashizume J, Akamatsu H, Akagi T, Kodama Y, Hamano H, Zamami Y, Ohyama K. Sakamoto T, et al. Among authors: ohyama k. Clin Drug Investig. 2024 Dec 24. doi: 10.1007/s40261-024-01414-7. Online ahead of print. Clin Drug Investig. 2024. PMID: 39718696 No abstract available.
Immune complexome analysis reveals an autoimmune signature predictive of COVID-19 severity.
Moriishi M, Takazono T, Hashizume J, Aibara N, Kutsuna YJ, Okamoto M, Sawai T, Hoshino T, Mori Y, Fukuda Y, Awaya Y, Yamanashi H, Furusato Y, Yanagihara T, Miyamoto H, Sato K, Kodama Y, Mizukami S, Sakamoto N, Yamamoto K, Sakamoto K, Yanagihara K, Izumikawa K, Maeda T, Nakashima M, Fukushima K, Mukae H, Ohyama K. Moriishi M, et al. Among authors: ohyama k. Clin Biochem. 2025 Jan;135:110865. doi: 10.1016/j.clinbiochem.2024.110865. Epub 2024 Dec 15. Clin Biochem. 2025. PMID: 39689808
Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database.
Sakamoto T, Miyamoto H, Hashizume J, Akamatsu H, Akagi T, Kodama Y, Hamano H, Zamami Y, Ohyama K. Sakamoto T, et al. Among authors: ohyama k. Clin Drug Investig. 2024 Oct;44(10):761-771. doi: 10.1007/s40261-024-01394-8. Epub 2024 Oct 14. Clin Drug Investig. 2024. PMID: 39402407
774 results